Treasurer Of The State Of North Carolina Sage Therapeutics, Inc. Transaction History

Treasurer Of The State Of North Carolina

$25 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$27.52 - $37.99 $520,816 - $718,960	-18,925 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$30.71 - $45.71 $9,213 - $13,713	300 Added 1.61%	18,925 $626,000
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $4,447 - $5,653	120 Added 0.65%	18,625 $792,000
Q3 2021 Nov 03, 2021	BUY	$40.26 - $57.37 $25,323 - $36,085	629 Added 3.52%	18,505 $820,000
Q2 2021 Aug 13, 2021	SELL	$54.88 - $79.29 $48,843 - $70,568	-890 Reduced 4.74%	17,876 $1.02 Million
Q1 2021 May 03, 2021	SELL	$70.65 - $96.76 $3,532 - $4,838	-50 Reduced 0.27%	18,766 $1.41 Million
Q4 2020 Feb 02, 2021	BUY	$58.41 - $89.06 $2,920 - $4,453	50 Added 0.27%	18,816 $1.63 Million
Q3 2020 Nov 04, 2020	SELL	$41.13 - $62.45 $822 - $1,249	-20 Reduced 0.11%	18,766 $1.15 Million
Q2 2020 Aug 07, 2020	SELL	$25.95 - $43.15 $472,523 - $785,718	-18,209 Reduced 49.22%	18,786 $781,000
Q1 2020 May 13, 2020	BUY	$26.15 - $77.24 $233,781 - $690,525	8,940 Added 31.87%	36,995 $1.06 Million
Q4 2019 Feb 12, 2020	BUY	$60.18 - $154.77 $7,823 - $20,120	130 Added 0.47%	28,055 $2.03 Million
Q3 2019 Nov 07, 2019	SELL	$140.29 - $189.96 $1.11 Million - $1.5 Million	-7,920 Reduced 22.1%	27,925 $3.92 Million
Q2 2019 Aug 23, 2019	BUY	$157.85 - $183.09 $373,630 - $433,374	2,367 Added 7.07%	35,845 $6.56 Million
Q1 2019 Aug 07, 2019	BUY	$89.33 - $163.65 $169,816 - $311,098	1,901 Added 6.02%	33,478 $5.33 Million
Q4 2018 Aug 07, 2019	SELL	$81.94 - $139.71 $819 - $1,397	-10 Reduced 0.03%	31,577 $3.03 Million
Q3 2018 Aug 07, 2019	BUY	$138.11 - $169.04 $2.95 Million - $3.62 Million	21,387 Added 209.68%	31,587 $4.46 Million
Q2 2018 Aug 07, 2019	BUY	$140.36 - $175.76 $1.43 Million - $1.79 Million	10,200 New	10,200 $1.6 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $333M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

News

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.

Account